Search Results 2321-2330 of 14765 for anti-TNF drugs

  1. The BEACON Study (Breast Cancer Outcomes With NKTR-102) - Mayo Clinic

    The primary study objective is to compare overall survival of patients who receive NKTR-102 given once every 21 days to patients who receive treatment of ...

  2. Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients with Advanced Cancers - Mayo Clinic

    Tumors that are relapsed or refractory to at least 1 prior anti-cancer systemic therapy and for which no standard therapy exists; Expansion cohort only ...

  3. Teclistamab-Cqyv (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Dactinomycin (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    By condition, treatment or drug name. Search tips. Study of TH-302 or ... Inability to discontinue non-steroidal anti-inflammatory drugs for 5 days ...

  6. Education and Training - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

    In the example presented featuring the PMM2 gene, over 1,500 missense variants were generated for protein structures. Then structural dynamics studies were ...

  7. Ado-Trastuzumab Emtansine (Intravenous Route) Precautions - Mayo Clinic

    Your doctor may test your heart before and during treatment. Contact your doctor right away if you have chest pain, increased coughing, trouble breathing, rapid ...

  8. Mayo Clinic Comprehensive Cancer Center — Research

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...

  9. Evinacumab-Dgnb (Intravenous Route) Description and Brand Names - Mayo Clinic

    Evinacumab-dgnb injection is used together with other medicines to treat homozygous familial hypercholesterolemia (HoFH). This medicine is an ANGPTL3 ( ...

  10. Ramucirumab (Intravenous Route) Proper Use - Mayo Clinic

    Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...